But a follow-up 2021 study, known as STEP 4, showed that within 48 weeks of no longer taking semaglutide, participants regained approximately two-thirds of their prior weight loss, while those who remained on GLP-1 drug therapy continued to lose weight
South Park: The End of Obesity will premiere on Paramount+ on May 24.
Our study stands out by focusing specifically on semaglutide, a long-acting GLP-1 receptor agonist, and its unique impact on cognitive impairment associated with diabetes
One can only imagine South Park: The End of Obesity is now streaming, exclusively on Paramount+
Joyce Solar RN - Cofounder/Master Injector Joyce Solar, RN, is the cofounder and Master Injector at Southern Oregon Medical Aesthetics Center with over 20 years of experience in medical aesthetics
Understanding the established side effect profile helps contextualise reports of burning skin sensations